Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDHF and Regulation of Cerebral and Muscle Blood Flow
NCT05176379Phase 4Recruiting
- Sponsor
- University of Oklahoma
- Start
- Feb 2022
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of fluconazole, sponsored by University of Oklahoma. Started Feb 2022; status: recruiting.
02
Drugs
fluconazole
Beyond the preview
Go deeper on NCT05176379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05176379.